Literature DB >> 30933526

Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein.

Rikiya Ohashi1, Reiko Watanabe1, Tsuyoshi Esaki1, Tomomi Taniguchi, Nao Torimoto-Katori, Tomoko Watanabe, Yuko Ogasawara, Tsuyoshi Takahashi, Mikiko Tsukimoto, Kenji Mizuguchi1.   

Abstract

For efficient drug discovery and screening, it is necessary to simplify P-glycoprotein (P-gp) substrate assays and to provide in silico models that predict the transport potential of P-gp. In this study, we developed a simplified in vitro screening method to evaluate P-gp substrates by unidirectional membrane transport in P-gp-overexpressing cells. The unidirectional flux ratio positively correlated with parameters of the conventional bidirectional P-gp substrate assay ( R2 = 0.941) and in vivo Kp,brain ratio (mdr1a/1b KO/WT) in mice ( R2 = 0.800). Our in vitro P-gp substrate assay had high reproducibility and required approximately half the labor of the conventional method. We also constructed regression models to predict the value of P-gp-mediated flux and three-class classification models to predict P-gp substrate potential (low-, medium-, and high-potential) using 2397 data entries with the largest data set collected under the same experimental conditions. Most compounds in the test set fell within two- and three-fold errors in the random forest regression model (71.3 and 88.5%, respectively). Furthermore, the random forest three-class classification model showed a high balanced accuracy of 0.821 and precision of 0.761 for the low-potential classes in the test set. We concluded that the simplified in vitro P-gp substrate assay was suitable for compound screening in the early stages of drug discovery and that the in silico regression model and three-class classification model using only chemical structure information could identify the transport potential of compounds including P-gp-mediated flux ratios. Our proposed method is expected to be a practical tool to optimize effective central nervous system (CNS) drugs, to avoid CNS side effects, and to improve intestinal absorption.

Entities:  

Keywords:  P-glycoprotein; correlation; in silico prediction; in vitro screening; machine learning; nonsubstrate; physicochemical parameters; substrate

Mesh:

Substances:

Year:  2019        PMID: 30933526     DOI: 10.1021/acs.molpharmaceut.8b01143

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology.

Authors:  Biljana Gatarić; Jelena Parojčić
Journal:  AAPS J       Date:  2019-12-10       Impact factor: 4.009

2.  Novel QSAR Approach for a Regression Model of Clearance That Combines DeepSnap-Deep Learning and Conventional Machine Learning.

Authors:  Hideaki Mamada; Yukihiro Nomura; Yoshihiro Uesawa
Journal:  ACS Omega       Date:  2022-05-11

Review 3.  Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery-A Concise Outlook.

Authors:  Sachin Rathod; Heta Desai; Rahul Patil; Jayant Sarolia
Journal:  AAPS PharmSciTech       Date:  2022-01-18       Impact factor: 3.246

4.  Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein.

Authors:  Holger Fischer; Mohammed Ullah; Cecile C de la Cruz; Thomas Hunsaker; Claudia Senn; Thomas Wirz; Björn Wagner; Dragomir Draganov; Faye Vazvaei; Massimiliano Donzelli; Axel Paehler; Mark Merchant; Li Yu
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

5.  A Machine Learning-Based Prediction Platform for P-Glycoprotein Modulators and Its Validation by Molecular Docking.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Cells       Date:  2019-10-21       Impact factor: 6.600

6.  Cancer Cell Membrane Decorated Silica Nanoparticle Loaded with miR495 and Doxorubicin to Overcome Drug Resistance for Effective Lung Cancer Therapy.

Authors:  Jinyuan He; Chulian Gong; Jie Qin; Mingan Li; Shaohong Huang
Journal:  Nanoscale Res Lett       Date:  2019-11-08       Impact factor: 4.703

7.  Random Forest Model Prediction of Compound Oral Exposure in the Mouse.

Authors:  Haseeb Mughal; Han Wang; Matthew Zimmerman; Marc D Paradis; Joel S Freundlich
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-26

8.  Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib.

Authors:  Rafal Dziadziuszko; Tiffany Hung; Kun Wang; Voleak Choeurng; Alexander Drilon; Robert C Doebele; Fabrice Barlesi; Charlie Wu; Lucas Dennis; Joel Skoletsky; Ryan Woodhouse; Meijuan Li; Ching-Wei Chang; Brian Simmons; Todd Riehl; Timothy R Wilson
Journal:  Mol Oncol       Date:  2022-04-22       Impact factor: 7.449

9.  Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans.

Authors:  Hideaki Mamada; Kazuhiko Iwamoto; Yukihiro Nomura; Yoshihiro Uesawa
Journal:  Mol Divers       Date:  2021-02-10       Impact factor: 3.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.